Supplement May Fight Acute Leukemia
Acute myeloid leukemia (AML), the most common form of blood and bone marrow cancer among adults, is known for its rapid progression and resistance to treatment. “Treating acute myeloid leukemia is challenging because of these persistent, leukemia-initiating stem cells, which are typically not targeted by most existing therapies,” says SandeepRead